Hasil Pencarian - Wouter H van Geffen

  • Menampilkan 1 - 9 hasil dari 9
Perbaiki Hasil
  1. 1
    High-flow nasal cannula oxygen therapy for admitted COPD-patients. A retrospective cohort study

    High-flow nasal cannula oxygen therapy for admitted COPD-patients. A retrospective cohort study oleh Pieter Veenstra, Nic J. G. M. Veeger, Ralph J. H. Koppers, Marieke L. Duiverman, Wouter H. van Geffen

    Diterbitkan 2022-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    High-flow nasal cannula oxygen therapy for admitted COPD-patients. A retrospective cohort study.

    High-flow nasal cannula oxygen therapy for admitted COPD-patients. A retrospective cohort study. oleh Pieter Veenstra, Nic J G M Veeger, Ralph J H Koppers, Marieke L Duiverman, Wouter H van Geffen

    Diterbitkan 2022-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    The electronic nose: emerging biomarkers in lung cancer diagnostics

    The electronic nose: emerging biomarkers in lung cancer diagnostics oleh Wouter H. van Geffen, Kevin Lamote, Adrien Costantini, Lizza E.L. Hendriks, Najib M. Rahman, Torsten G. Blum, Jan van Meerbeeck

    Diterbitkan 2019-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    ERS International Congress 2022: highlights from the Thoracic Oncology Assembly

    ERS International Congress 2022: highlights from the Thoracic Oncology Assembly oleh Maria Joana Catarata, Wouter H. Van Geffen, Radhika Banka, Beatriz Ferraz, Calvin Sidhu, Alan Carew, Lucia Viola, Rolof Gijtenbeek, Georgia Hardavella

    Diterbitkan 2023-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    Overall survival in advanced epidermal growth factor receptor mutated non-small cell lung cancer using different tyrosine kinase inhibitors in The Netherlands: a retrospective, nationwide registry studyResearch in context

    Overall survival in advanced epidermal growth factor receptor mutated non-small cell lung cancer using different tyrosine kinase inhibitors in The Netherlands: a retrospective, nat... oleh Rolof G.P. Gijtenbeek, Ronald A.M. Damhuis, Anthonie J. van der Wekken, Lizza E.L. Hendriks, Harry J.M. Groen, Wouter H. van Geffen

    Diterbitkan 2023-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    Continuous professional development: elevating thoracic oncology education in Europe

    Continuous professional development: elevating thoracic oncology education in Europe oleh Wouter H. van Geffen, Torsten G. Blum, Stefano Aliberti, Kevin G. Blyth, Clementine Bostantzoglou, Amy Farr, Bogdan Grigoriu, Georgia Hardavella, Rudolf M. Huber, Nick Maskell, Gilbert Massard, Najib M. Rahman, Daiana Stolz, Jan van Meerbeeck

    Diterbitkan 2019-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    Prognostic Implication of KRAS G12C Mutation in a Real-World KRAS-Mutated Stage IV NSCLC Cohort Treated With Immunotherapy in The Netherlands

    Prognostic Implication of KRAS G12C Mutation in a Real-World KRAS-Mutated Stage IV NSCLC Cohort Treated With Immunotherapy in The Netherlands oleh Anneloes L. Noordhof, MD, Esther M. Swart, MSc, Ronald A.M. Damhuis, PhD, Lizza E.L. Hendriks, MD, PhD, Peter W.A. Kunst, MD, PhD, Mieke J. Aarts, PhD, Wouter H. van Geffen, MD, PhD

    Diterbitkan 2023-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    Randomised controlled trial of first-line tyrosine-kinase inhibitor (TKI) versus intercalated TKI with chemotherapy for EGFR-mutated nonsmall cell lung cancer

    Randomised controlled trial of first-line tyrosine-kinase inhibitor (TKI) versus intercalated TKI with chemotherapy for EGFR-mutated nonsmall cell lung cancer oleh Rolof G.P. Gijtenbeek, Vincent van der Noort, Joachim G.J.V. Aerts, Jeske A. Staal-van den Brekel, Egbert F. Smit, Frans H. Krouwels, Frank A. Wilschut, T. Jeroen N. Hiltermann, Wim Timens, Ed Schuuring, Joost D.J. Janssen, Martijn Goosens, Paul M. van den Berg, A. Joop de Langen, Jos A. Stigt, Ben E.E.M. van den Borne, Harry J.M. Groen, Wouter H. van Geffen, Anthonie J. van der Wekken

    Diterbitkan 2022-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  9. 9
    Timely administration of tocilizumab improves outcome of hospitalized COVID-19 patients.

    Timely administration of tocilizumab improves outcome of hospitalized COVID-19 patients. oleh Abraham Rutgers, Peter E Westerweel, Bronno van der Holt, Simone Postma, Marit G A van Vonderen, Djura P Piersma, Douwe Postma, Maarten van den Berge, Eefje Jong, Marten de Vries, Leonie van der Burg, Dennis Huugen, Marjolein van der Poel, Linda M Kampschreur, Marcel Nijland, Jaap H Strijbos, Menno Tamminga, Pim G N J Mutsaers, Suzanne Schol-Gelok, Margriet Dijkstra-Tiekstra, Grigory Sidorenkov, Julien Vincenten, Wouter H van Geffen, Marjolein Knoester, Jos Kosterink, Reinold Gans, Coen Stegeman, Gerwin Huls, Tom van Meerten

    Diterbitkan 2022-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: